129 related articles for article (PubMed ID: 38330830)
1. PIRADS≥4 MRI lesion: Is performing systematic biopsies still essential for detecting clinically significant prostate cancer?
Taha F; Branchu B; Demichel N; Goudaimy S; Bui AP; Delchet O; Larre S
Fr J Urol; 2024 Mar; 34(2):102572. PubMed ID: 38330830
[TBL] [Abstract][Full Text] [Related]
2. Not All Multiparametric Magnetic Resonance Imaging-targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer.
Stabile A; Dell'Oglio P; Gandaglia G; Fossati N; Brembilla G; Cristel G; Dehò F; Scattoni V; Maga T; Losa A; Gaboardi F; Cardone G; Esposito A; De Cobelli F; Del Maschio A; Montorsi F; Briganti A
Eur Urol Oncol; 2018 Jun; 1(2):120-128. PubMed ID: 31100235
[TBL] [Abstract][Full Text] [Related]
3. Multicenter transperineal MRI-TRUS fusion guided outpatient clinic prostate biopsies under local anesthesia.
Jacewicz M; Günzel K; Rud E; Lauritzen PM; Galtung KF; Hinz S; Magheli A; Baco E
Urol Oncol; 2021 Jul; 39(7):432.e1-432.e7. PubMed ID: 33257219
[TBL] [Abstract][Full Text] [Related]
4. Is targeted magnetic resonance imaging/transrectal ultrasound fusion prostate biopsy enough for the detection of prostate cancer in patients with PI-RADS ≥3: Results of a prospective, randomized clinical trial.
Zhang J; Zhu A; Sun D; Guo S; Zhang H; Liu S; Fu Q; Zhang K
J Cancer Res Ther; 2020; 16(7):1698-1702. PubMed ID: 33565519
[TBL] [Abstract][Full Text] [Related]
5. Predictors of prostate cancer detection in MRI PI-RADS 3 lesions - Reality of a tertiary center.
Araújo D; Gromicho A; Dias J; Bastos S; Maciel RM; Sabença A; Xambre L
Arch Ital Urol Androl; 2023 Dec; 95(4):11830. PubMed ID: 38117217
[TBL] [Abstract][Full Text] [Related]
6. MRI-guided in-bore biopsy of the prostate - defining the optimal number of cores needed.
Gross M; Eisenhuber E; Assinger P; Schima R; Susani M; Doblhammer S; Schima W
Cancer Imaging; 2024 Jul; 24(1):81. PubMed ID: 38956721
[TBL] [Abstract][Full Text] [Related]
7. A Prospective Comparison of Transrectal Standard, Cognitive, Transperineal Fusion, and Mapping Prostate Biopsy for Cancer Detection.
Petov V; Bazarkin A; Morozov A; Taratkin M; Ganzha T; Danilov S; Chernov Y; Chinenov D; Rzayev R; Suvorov A; Amosov A; Fajkovic H; Enikeev D; Krupinov G
J Endourol; 2023 Aug; 37(8):940-947. PubMed ID: 37294206
[No Abstract] [Full Text] [Related]
8. Clinical study of multifactorial diagnosis in prostate biopsy.
Li J; Wang K; Li S; Wu P; Wang X; He Y; Tang W
Prostate; 2023 Nov; 83(15):1494-1503. PubMed ID: 37545333
[TBL] [Abstract][Full Text] [Related]
9. Transperineal vs transrectal magnetic resonance and ultrasound image fusion prostate biopsy: a pair-matched comparison.
Kaneko M; Medina LG; Lenon MSL; Hemal S; Sayegh AS; Jadvar DS; Ramacciotti LS; Paralkar D; Cacciamani GE; Lebastchi AH; Salhia B; Aron M; Hopstone M; Duddalwar V; Palmer SL; Gill IS; Abreu AL
Sci Rep; 2023 Aug; 13(1):13457. PubMed ID: 37596374
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer detection rate in men undergoing transperineal template-guided saturation and targeted prostate biopsy.
Kaufmann B; Saba K; Schmidli TS; Stutz S; Bissig L; Britschgi AJ; Schaeren E; Gu A; Langenegger N; Sulser T; Eberli D; Keller EX; Hermanns T; Poyet C
Prostate; 2022 Feb; 82(3):388-396. PubMed ID: 34914121
[TBL] [Abstract][Full Text] [Related]
11. Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study.
van der Leest M; Cornel E; Israël B; Hendriks R; Padhani AR; Hoogenboom M; Zamecnik P; Bakker D; Setiasti AY; Veltman J; van den Hout H; van der Lelij H; van Oort I; Klaver S; Debruyne F; Sedelaar M; Hannink G; Rovers M; Hulsbergen-van de Kaa C; Barentsz JO
Eur Urol; 2019 Apr; 75(4):570-578. PubMed ID: 30477981
[TBL] [Abstract][Full Text] [Related]
12. MRI/US fusion prostate biopsy in men on active surveillance: Our experience.
Lacetera V; Antezza A; Papaveri A; Cappa E; Cervelli B; Gabrielloni G; Montesi M; Morcellini R; Parri G; Recanatini E; Beatrici V
Arch Ital Urol Androl; 2021 Mar; 93(1):88-91. PubMed ID: 33754618
[TBL] [Abstract][Full Text] [Related]
13. Value of magnetic resonance imaging/ultrasound fusion prostate biopsy to select patients for focal therapy.
Ganzer R; Mangold A; Siokou FS; Brinkschmidt C; Brummeisl W
World J Urol; 2022 Nov; 40(11):2689-2694. PubMed ID: 36152071
[TBL] [Abstract][Full Text] [Related]
14. Comparison of prostate cancer detection rates in patients undergoing MRI/TRUS fusion prostate biopsy with two different software-based systems.
Hanske J; Risse Y; Roghmann F; Pucheril D; Berg S; Tully KH; von Landenberg N; Wald J; Noldus J; Brock M
Prostate; 2022 Feb; 82(2):227-234. PubMed ID: 34734428
[TBL] [Abstract][Full Text] [Related]
15. Can we omit systematic biopsies in patients undergoing MRI fusion-targeted prostate biopsies?
Leow JJ; Koh SH; Chow MW; Loke W; Salada R; Hong SK; Yeow Y; Lee CH; Tan CH; Tan TW
Asian J Androl; 2023; 25(1):43-49. PubMed ID: 35488666
[TBL] [Abstract][Full Text] [Related]
16. Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study.
Rouvière O; Puech P; Renard-Penna R; Claudon M; Roy C; Mège-Lechevallier F; Decaussin-Petrucci M; Dubreuil-Chambardel M; Magaud L; Remontet L; Ruffion A; Colombel M; Crouzet S; Schott AM; Lemaitre L; Rabilloud M; Grenier N;
Lancet Oncol; 2019 Jan; 20(1):100-109. PubMed ID: 30470502
[TBL] [Abstract][Full Text] [Related]
17. Transperineal freehand multiparametric MRI fusion targeted biopsies under local anaesthesia for prostate cancer diagnosis: a multicentre prospective study of 1014 cases.
Marra G; Zhuang J; Beltrami M; Calleris G; Zhao X; Marquis A; Kan Y; Oderda M; Huang H; Faletti R; Zhang Q; Molinaro L; Wang W; Bergamasco L; Guo H; Gontero P
BJU Int; 2021 Jan; 127(1):122-130. PubMed ID: 32455504
[TBL] [Abstract][Full Text] [Related]
18. MRI-TRUS fusion guided prostate biopsy - initial experience and assessment of the role of contralateral lobe systematic biopsy.
Andras I; Crisan D; Cata E; Tamas-Szora A; Caraiani C; Coman RT; Bungardean C; Mirescu C; Coman I; Crisan N
Med Ultrason; 2019 Feb; 21(1):37-44. PubMed ID: 30779829
[TBL] [Abstract][Full Text] [Related]
19. Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer.
Stabile A; Dell'Oglio P; De Cobelli F; Esposito A; Gandaglia G; Fossati N; Brembilla G; Cristel G; Cardone G; Deho' F; Losa A; Suardi N; Gaboardi F; Del Maschio A; Montorsi F; Briganti A
Eur Urol Oncol; 2018 May; 1(1):29-36. PubMed ID: 31100225
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of elastic fusion biopsy: Comparing prostate cancer detection between targeted and systematic biopsy.
Oderda M; Albisinni S; Benamran D; Calleris G; Ciccariello M; Dematteis A; Diamand R; Descotes JL; Fiard G; Forte V; Giacobbe A; Marquis A; Marra G; Messas A; Muto G; Peltier A; Rius L; Simone G; Roumeguere T; Faletti R; Gontero P
Prostate; 2023 Feb; 83(2):162-168. PubMed ID: 36259316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
